Status:
WITHDRAWN
Assessing Myocardial Blood Flow and Blood Flow Reserve by Transoesophageal Echocardiography (TEE)
Lead Sponsor:
University Hospital, Basel, Switzerland
Conditions:
Coronary Artery Disease
Eligibility:
All Genders
18+ years
Phase:
PHASE1
PHASE2
Brief Summary
Until today it was not possible to reliably assess the function of a new bypass, i.e., to measure myocardial perfusion. Measuring intramyocardial blood flow directly after revascularisation would grea...
Detailed Description
Until today it was not possible to reliably assess the function of a new bypass, i.e., to measure myocardial perfusion. Measuring intramyocardial blood flow directly after revascularisation would grea...
Eligibility Criteria
Inclusion
- Part I: Patients with angiographically normal coronary vessels undergoing elective valve surgery or patients with coronary artery disease (CAD) who are planned for elective CABG surgery
- Part II: Patients with CAD who are planned for elective CABG surgery and who had SPECT including adenosine for hyperemia before surgery
Exclusion
- No consent
- Acute coronary syndrome
- Acute heart failure
- Left ventricular ejection fraction \< 30%
- Pronounced pulmonary artery hypertension
- Known adverse reaction against Optison or SonoVue or their components
- Severe renal or hepatic insufficiency
- Severe obstructive lung disease
Key Trial Info
Start Date :
August 1 2006
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2008
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT00286559
Start Date
August 1 2006
End Date
December 1 2008
Last Update
March 25 2015
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.